Princeton Alpha Management’s ResMed RMD Stock Holding History

Princeton Alpha Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,155	Closed	-$658K	–	839
2016 Q3	$658K	Buy	+10,155	New	+$676K	0.12%	268
2016 Q1	–	Sell	-11,630	Closed	-$624K	–	890
2015 Q4	$624K	Buy	11,630 +7,291	+168%	+$411K	0.11%	285
2015 Q3	$221K	Buy	4,339 +1	+0%	+$54	0.05%	571
2015 Q2	$245K	Buy	+4,338	New	+$274K	0.05%	533

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

Princeton Alpha Management's RMD Position: Q4 2016 in Review

Princeton Alpha Management sold out of ResMed (RMD) in Q4 2016, closing a stake of 10,155 shares — an estimated $658K sold.

Princeton Alpha Management first reported a position in RMD in Q2 2015 and held it in 4 quarters. The position peaked at $658K in Q3 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

Princeton Alpha Management reported no remaining ResMed position as of Q4 2016 after selling out during the quarter.
Princeton Alpha Management sold 10,155 ResMed shares in Q4 2016, an estimated $658K.
Princeton Alpha Management first reported a position in ResMed in Q2 2015 and held it in 4 quarters.
Princeton Alpha Management's ResMed position peaked at $658K in Q3 2016.
361 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on Princeton Alpha Management's 13F filing for Q4 2016, filed 10 Feb 2017.